Office: 650A Salk Hall
Kim Coccodrilli Coley, PharmD, FCCP is a Professor of Pharmacy and Therapeutics at the University of Pittsburgh School of Pharmacy. She received her Bachelor of Science degree in pharmacy from the University of Pittsburgh and her Doctor of Pharmacy degree from the Philadelphia College of Pharmacy and Science.
Dr. Coley's research focuses on evaluating clinical outcomes of medications and examining patient and system factors that impact beneficial and adverse outcomes to medications. She has worked extensively with clinical electronic medical records to evaluate drug safety and effectiveness in large patient cohorts. Additionally, Dr. Coley conducts patient-centered research that focuses on the role of the pharmacist in improving medication adherence and patient outcomes in the community and during care transitions.
She is particularly interested in the changing roles of pharmacists in the current health care environment and study the impact of new pharmacy care models. Dr. Coley serves on several national pharmacy award panels and is a reviewer for numerous psychiatry and pharmacy journals.
Dr. Coley conducts pharmacy practice-based research focusing on developing and implementing innovative patient care models in a community pharmacy setting.
Coley KC, Verrico MM, McNamara DM, Park SC, Cressman MD, Branch RA. Lack of tacrolimus-induced cardiomyopathy. Ann Pharmacother 2001;35(9):985-989.
Conley EL, Coley KC, Pollock BG, DaPos SV, Maxwell R, Branch RA. Valproic Acid and thrombocytopenia: experience at a psychiatric teaching hospital. Pharmacotherapy 2001;21(11):1325-1330.
Calabrese AT, Coley KC, DaPos SV, Swanson D, Rao RH. Risk of lactic acidosis with metformin: an evaluation of prescribing practices. Arch Intern Med 2002.162;434-437.
Coley KC, Dapos SV, Williams BA, Chen C, Smith RB. Retrospective evaluation of unanticipated admissions and readmissions after same day surgery and associated costs. J Clin Anesth. 2002 (14):349-53.
Steinmetz KL, Coley KC, Pollock BG: Assessment of geriatric information in the drug label for commonly prescribed drugs in the elderly. J Am Geriatr Soc. 2005;53(5):891-4.
Coley KC. Aripiprazole Use and Continuation Rates During Psychiatric Hospitalization. Ann Pharmacother 2005;39:1367-8.
Angalakuditi M, Coley KC, Krenzelok E. Children’s acetaminophen exposures reported to a regional poison control center. Am J Health-Syst Pharm 2006;63:323-6.
Coley KC, Pringle JP, Weber RJ, Rice K, Ramanujam R, Sirio C. Perceived barriers in using a region-wide medication error reporting system. J Patient Saf 2006;2(1):39-44.
Corman SL*, Coley KC, Schonder KE. Effect of long-term tacrolimus immunosuppression on renal function in liver transplant recipients. Pharmacotherapy 2006.26(10):1433-7.
Angalakuditi M, Coley KC, Kirisci L, Saul MI, Painter L. Association between in-hospital falls and chronic disease, drug use, and anemia: A matched case-control study. J Patient Saf 2007;3:16-21.
Angalakuditi M, Coley KC. Impact of drug use and comorbidities on in-hospital falls in patients with chronic kidney disease. Ann Pharmacother 2007;41:1638-43.
Bigos K, Pollock BG, Coley KC, Marder SR, Miller D, Bies RR. Sex, race and smoking impact olanzapine exposure. J Clin Pharmacol 2008;48:157-65.
Feng Y, Pollock BG, Coley K, Marder SR, Miller D, Kirshner M, Aravagiri M, Schneider L, Bies RR. Population pharmacokinetic analysis for risperidone using highly sparse sampling measurements form the CATIE study. Br. J Pharmacol. 2008;66(5):629-39.
Coley KC, Fabian T, Kim E, Scipio T*, Ammerman DK, Saul M, Whitehead R, Ganguli R. Predictors of Aripiprazole Treatment Continuation in Hospitalized Patients. J Clin Psychiatry. 2008;69(9):1393-7.
Coley KC, Scipio TM*, Fabian TJ, Ruby C, Lenze EJ. Aripiprazole prescribing patterns and side effects in elderly psychiatric inpatients. J Psychiatric Practice. 2009;15(2):150-3.
Coley KC, Saul MI, Seybert A. Economic burden of not recognizing panic disorder in the emergency department. J Emerg Med. 2009; 36(1):3-7.
Palkovic LB, Sokos DR, Coley KC. Evaluation of clinical characteristics as predictors for the inappropriate prescribing of acid suppressive therapy in internal medicine inpatients. Int J Pharm Pract. 2009; 17(1):73-75.
Jin Y, Pollock BG, Coley K, Miller D, Marder S, Florian J, Schneider L, Lieberman J, Kirshner M, Bies RR. Population pharmacokinetics of perphenazine in schizophrenia patients from CATIE: Impact of race and smoking. J Clin Pharmacology. 2010;50(1):73-80.
Diehl JL, Daw JR, Coley KC, Rayburg R. Medical utilization associated with palivizumab compliance in a commercial and managed Medicaid health plan. J Managed Care Pharm 2010;16(1):23-31.
Lavsa S, Fabian T, Corman SC, Coley KC. Influence of medications and diagnosis on fall risk in psychiatric inpatients. Am J Health-Syst Pharm 2010;67:1274-80.
Wessels AM, Bies RR, Pollock BG, Schneider LS, Lieberman JA, Stroup S, Li CH, Coley KC, Kirshner MM, Marder SR. Population Pharmacokinetic modeling of ziprasidone in patients with schizophrenia from the CATIE study. J Clin Pharmacol. 2011;51:1587-91.
Osborne MA, Snyder ME, Hall DL, Coley KC, McGivney MS. Evaluating Pennsylvania pharmacists’ provision of community-based patient care services to develop a statewide practice network. Innovations in Pharmacy 2011;2(4):1-18.
Deusenberry CM, Coley KC, Korytkowski MT, Donihi AC. Hypoglycemia in hospitalized patients treated with sulfonylureas. Pharmacotherapy 2012;32(7):613-617.
Kim JK, Mohommad RA, Coley KC, Donihi AC. Evaluation of an iPad to Provide Warfarin Video Education in the Inpatient Setting. J Patient Safety 2014. EPub ahead of Print. PMID:2452209.
Kreys TJM, Fabian TJ, Saul MI, Haskett R, Coley KC. An Evaluation of Inpatient Treatment Continuation and Hospital Readmission Rates in Bipolar Disorder Patients Treated with Aripiprazole or Quetiapine. J Psychiatric Practice. 2013;19(4):299-295. PMID:23852103.
Sakely H, Corbo J, Coley K, McGivney M, Thorpe C, Klatt P, Schleiden L, Zaharoff J, Cox-Vance L, Balestrino V. Pharmacist-led collaborative practice for older adults. Am J Health-Syst Pharm 2015; 72:606-609. PMID: 25825181.
Pringle JL, Coley KC. Improving medication adherence: A framework for community pharmacy-based interventions. Integrated Pharm Res Pract. 2015;4:175-183.
Snyder ME, Frail CK, Gemant SA, Bacci JL, Coley KC, Colip L, Ferreri SP, Hagemeiier NE, Rodis JL, Smith MG, McGivney MS, Smith RB. Fellowships in Community Pharmacy Research: Experiences of Five Schools and Colleges of Pharmacy. J Am Pharmacists Assoc. 2016 May-Jun;56(3):316-22. PMID 27083852
Bacci JL, Coley KC, McGrath K, Abraham O, Adams AJ, McGivney MS. Strategies to facilitate implementation of collaborative practice agreements in chain community pharmacies. J Am Pharmacists Assoc. 2016 May-Jun;56(3):257-265. PMID 27053276
Predicting Aripiprazole Treatment Success in Patients Admitted to a Psychiatric Hospital. Bristol-Myers Squibb. 2006. $155,000. Primary Investigator.
Study of Medication Adherence and its Relationship to the Therapeutic Alliance. AstraZeneca. $50,000. Co-Investigator.
Bridging the Medication Use Gap from Hospital to Home: Development of a Continuity of Care Record. Primary Investigator. ASHP Foundation. 2008-2012. $200,000. Primary Investigator.
Pharmacist Management of Polypharmacy: Reducing Fall Risk in Elderly Psychiatric Inpatients. Co-Investigator. Jewish Healthcare Foundation. 2008. $15,000. Co-Investigator.
Evaluation of Comorbidities, Prescribing Patterns, and Resource Use in Patients Presenting with Gout in a Large, Healthcare System. Primary Investigator. Takeda Pharmaceuticals. 2010-2012. $95,000. Primary Investigator.
Collaborating and Advancing Relationships: Pharmacist Advocates in Care Transitions (CARE PACT). Primary Investigator. Jewish Healthcare Foundation. 2010-2012. $93,000. Primary Investigator.
Implementation of an Inpatient Bulk Meds to Home Program at a Large Academic Medical Center. Senior Investigator. ASHP Foundation. 2012-2013. $25,000.
PIVOTS: Pharmacist Led Intervetions on Transitions of Seniors. Senior Investigator. Senior Investigator. ASHP Foundation. 2013-2015. $20,000.
Transforming the role of the hospital pharmacist to improve patients' access, adherence, and self-management of medication after discharge. Co-Investigator. The Beckwith Institute. 2013-2014. $24,450.
Pharmacist Led Interventions on Transitions of Seniors. Primary Investigator. Jewish Healthcare Foundation. 2013-2015. $60,000.
Improving vaccination rates through community partnerships and technology. NACDS/CDC. 2016. Primary Investigator
Pharmacist Led Interventions on Transitions of Seniors. Jewish Healthcare Foundation. 2013-2015. Primary Investigator